Skip to main content
Press Enter
BASF offers the world's largest portfolio of chemical raw materials for the pharmaceutical industry, ensuring the needs of our partners are always met. Every step of biopharmaceutical manufacturing requires high-quality raw materials delivered through a transparent, sustainable supply chain. BASF Biopharma Ingredients is committed to meeting your requirements for every ingredient we supply to the biologics industry. At BASF, we create excipients that are safe, effective, and convenient for your customers. Whether you’re developing orally disintegrating formulations that require taste-masking or modified release tablets, BASF has ingredients to deliver the precision you need, every time. At BASF, we offer a comprehensive range of cutting-edge solubilization polymers, and have an unparalleled understanding of the corresponding process technologies. BASF offers an unparalleled portfolio of excipients for topical formulations, enabling you with the tools to overcome formulation challenges. With products based on over 150 years of industry experience, BASF is committed to maintaining the highest level of quality across the product spectrum. BASF offers a broad portfolio of chemistries designed to simplify the product development process. Coating polymers are suitable for a variety of oral formulation challenges. As multifunctional excipients, ethoxylated solubilizers are known for their utility across a large range of dosage form classes. BASF's pharma grade lipid-based excipients are manufactured in GMP-compliant facilities with high quality and reliability in mind. BASF's portfolio of poloxamers are renown for their best-in-class quality. Consisting of a broad portfolio of polyethylene glycols (PEGs), BASF's portfolio of ethoxylated polymer-solubilizers is known for its versatility across a myriad of dosage forms. BASF offers a broad portfolio of functional excipients including our pharmaceutical grade polysorbate and sorbitan esters. Povidones, copovidones, and crospovidones are versatile materials that serve as the foundation of oral solid dosage forms. BASF's portfolio of solvents and co-solvents are suitable for a wide range of applications and processing methodologies. BASF offers a broad portfolio of brand families that are suitable for oral, topical, parenteral, and biologic applications. Coprocessed excipients are combination, all-in-one solutions. Kollicoat® coating polymers are suitable for a variety of oral formulation challenges. Kollicream® pharma grade solvents and emollients are manufactured in GMP-compliant facilities with high quality and reliability in mind. Kollidon® povidones, copovidones, and crospovidones are versatile materials that are most commonly used for solid oral dosage forms. Kolliphor® solubilizers, emulsifiers, co-emulsifiers, and surfactants enable the development of safe and effective formulations. Kollisolv® solubilizers and solvents are suitable for a wide range of applications and processing methodologies. Kolliwax® structuring agents, moisture barriers, and lubricants enable the formulation of various dosage forms. Novata® hard fats are structuring agents and matrix builders. Soluplus® is a novel solubilizer, crystallization inhibitor, and a matrix forming polymer. Explore this collection of resources to learn more about our innovative research and pharma solutions.
Date & Time Jun 18 - 19, 2024 8:30 AM - 4:30 PM CET
In-Person / Virtual In-Person
Location The Venue@DMU, 20 Western Blvd Leicester, LE2 7BU, United Kingdom

Tabletting School 2024

While providing valuable recommendations regarding the operation of tabletting equipment, discussing modern concepts of drug product development, and underpinned by the practical content with scientific explanations, Tabletting School addresses the needs of operators, formulators and lab heads or managers in an equal way.

Key takeaways:

  • Introduction to the tabletting process: equipment, tools & critical parameters
  • Accelerating drug product development by employing a compaction simulation.
  • Benefitting from computer aided systems in early drug product development. 
  • Using QbD methodology (QTPP, CQAs, RA) during formulation development.
  • Utilising the benefits of experimental design (DoE) using a multivariate approach. 
  • Interpreting the USP 1062 tablet compression characterisation guidance.
  • Analysing the relationship between formulation factors and compaction responses. 
  • Scaling-up a tabletting process from small to production scale equipment. 
  • Insight into continuous manufacturing principles.

BASF Experts

Thorsten Cech round

Thorsten Cech
Application Expert and 
Manager Application Lab,     BASF Pharma Solutions

LinkedIn Profile
Nils Rottmann round

Nils Rottmann
Project Manager Technical Service Europe, 
BASF Pharma Solutions

Guest Speaker

Walkiria Schlindwein round

Walkiria Schlindwein
Pharmaceutical Quality by Design course leader, De Montfort University

LinkedIn Profile
Kendal Pitt round

Kendal Pitt
Former Senior Technical Director in Global Manufacturing and Supply, GSK

LinkedIn Profile
Gavin Reynolds round

Gavin Reynolds
Pharmaceutical Technology and Development, Operations, AstraZeneca

LinkedIn Profile
Mariana Bezerra round

Mariana Bezerra
Senior Formulation Scientist,

LinkedIn Profile
Rob Blanchard

Rob Blanchard
Research, Development and Quality Systems Manager,
I Holland Ltd

LinkedIn Profile
Fiederike Guetter round

Friederike Gütter
Process Specialist,

LinkedIn Profile
Bruno Leclerq round

Bruno Leclercq
Business Development, Pharmacist, MEDELPHARM

LinkedIn Profile
Lucile Kubiak

Lucile Kubiak
Formulation Scientist, MEDELPHARM

LinkedIn Profile
Dirk Vanderroost round 1

Dirk Vanderroost
Area Sales Manager Continuous Technologies, GEA

LinkedIn Profile
Stuart Little round

Stuart Little
Systems Engineer, JMP

LinkedIn Profile
Sunny Singh round

Sunny Singh
Sales Specialist, Sotax

LinkedIn Profile